Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4695 USD | +3.01% | +7.81% | -18.35% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 9.04M |
---|---|---|---|---|---|
Net income 2024 * | -4M | Net income 2025 * | -13M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.76
x | P/E ratio 2025 * |
-1.57
x | Employees | 4 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.29% |
Latest transcript on Virios Therapeutics, Inc.
1 day | +3.01% | ||
1 week | +7.81% | ||
Current month | -2.00% | ||
1 month | +9.16% | ||
3 months | +14.51% | ||
6 months | -8.87% | ||
Current year | -18.35% |
Managers | Title | Age | Since |
---|---|---|---|
Gregory Duncan
CEO | Chief Executive Officer | 59 | 17-12-31 |
Angela Walsh
DFI | Director of Finance/CFO | 58 | 20-03-31 |
Ralph Grosswald
COO | Chief Operating Officer | 55 | 20-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Thomas
BRD | Director/Board Member | 70 | 20-12-20 |
Richard Whitley
BRD | Director/Board Member | 78 | 20-12-20 |
Gregory Duncan
CEO | Chief Executive Officer | 59 | 17-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.4695 | +3.01% | 40,647 |
24-04-25 | 0.4558 | +7.20% | 64,289 |
24-04-24 | 0.4252 | -1.35% | 200,892 |
24-04-23 | 0.431 | +1.25% | 78,947 |
24-04-22 | 0.4257 | -2.25% | 72,087 |
Delayed Quote Nasdaq, April 26, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.35% | 9.04M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- VIRI Stock